Abstract dark red curved lines background

Asset Deal, Stock Deal, or MSO? Structuring a Healthcare Transaction in NY

Asset Deal, Stock Deal, or MSO? Structuring a Healthcare Transaction in NY

Healthcare transactions in New York are highly scrutinized, so you may wonder which structure is the most appropriate choice. Of course, this depends on what you need, but you can pick the right option with confidence when an attorney is there to assist you. Whether you’re looking at an asset deal, stock deal, or MSO, our team is ready to help. 

The attorneys at Daniels, Porco & Lusardi, LLP help you analyze your transaction to structure it most appropriately, all while complying with New York’s strict compliance environment.  

Understanding the Corporate Practice of Medicine in New York

New York is one of the most aggressively enforced CPOM states. Only licensed professionals or professional entities (PLLCs, PCs) may own, control, or receive revenue tied to clinical services. Non-clinical entities, such as management companies, investors, private equity sponsors, must remain on the administrative side of the business.

This single rule eliminates or complicates many transaction structures that are common in other states. It also makes the choice between an asset deal, stock deal, or MSO model a strategic decision rather than a simple tax or liability question.

Asset Deals in NY Healthcare

An asset deal involves purchasing the practice’s assets, such as equipment, leasehold interests, patient records (with proper HIPAA compliance), intellectual property, and goodwill—while leaving liabilities behind unless specifically assumed.

Advantages include:

  • Buyer avoids legacy liabilities.
  • Clean transition for billing, credentialing, and compliance.
  • Allows restructuring into a new professional entity owned by physicians.

Challenges in NY include:

  • Only a licensed professional entity may acquire clinical assets.
  • Patient record transfers require HIPAA-compliant notices and continuity-of-care planning.
  • Payer contracts often need to be renegotiated or re-credentialed.

Asset deals are often the preferred structure when the goal is to refresh compliance, modernize operations, or transition ownership to new physicians while keeping non-clinical investors at arm’s length.

Stock Deals in NY Healthcare

A stock deal (or membership interest purchase for PLLCs) involves acquiring the ownership interests of the existing professional entity.

Advantages include:

  • Payer contracts, tax IDs, and billing infrastructure remain intact.
  • Minimal disruption to clinical operations.
  • No need to transfer patient records or re-credential providers.

Challenges in NY include:

  • Only licensed physicians may own the stock of a professional corporation or membership interests in a PLLC.
  • Buyer inherits all liabilities, such as regulatory, billing, employment, and malpractice tail exposure.
  • Any non-clinical investor must structure involvement through a compliant MSO arrangement.

Stock deals are typically used when continuity is critical and the physician-owners are simply changing hands. Private equity buyers cannot directly acquire stock in a professional entity, making this structure viable only for physician-to-physician transactions.

MSO Model: The New York Standard for PE-Backed Healthcare

Because non-physicians cannot own or control a medical practice in New York, the Management Services Organization (MSO) model has become the dominant structure for private equity and non-clinical investors.

Under this model:

  • Physicians own and control the professional entity (PC or PLLC).
  • The MSO, owned by investors, provides administrative, non-clinical services.
  • The MSO receives a fair market value (FMV) management fee, not a percentage of clinical revenue.
  • The MSO may acquire non-clinical assets through an asset deal.

Advantages include:

  • Fully compliant with NY CPOM rules.
  • Allows investors to scale operations, centralize management, and build platform efficiencies.
  • Physicians retain clinical autonomy.

Challenges include:

  • FMV analysis is mandatory to avoid fee-splitting violations.
  • Management agreements must be carefully drafted to avoid any appearance of clinical control.
  • Transactions often require dual closings: one for clinical assets (to the PC/PLLC) and one for non-clinical assets (to the MSO).

Choosing the Right Structure

In New York, the decision often comes down to who the buyer is and what the long-term operational model looks like:

  • Physician Buyer: Asset deal or stock deal.
  • Private Equity or Non-Clinical Investor: MSO model with a compliant asset acquisition.
  • Platform Expansion: MSO acquisition of non-clinical assets plus physician-owned professional entity alignment.

Choose the Structure That Is Most Appropriate for Your NY Healthcare Transaction

Having the advice of experienced legal counsel is critical to picking the right option and complying with New York’s complex laws. We understand the common pitfalls and issues clients face, how to avoid them, and how to maximize your ROI along the way. 

The attorneys at Daniels, Porco & Lusardi, LLP are ready to help. Contact us today for a consultation.